SOLO1: 7-year follow-up highlights the value of Olaparib maintenance
This transcript has been edited for clarity. I am Dr. Maurie Markman from the Cancer Treatment Centers of America. I want to talk about a very interesting article that recently appeared in the Journal of Clinical Oncologytitled “Overall survival with maintenance of olaparib at 7-year follow-up in patients with newly diagnosed advanced ovarian cancer and …
SOLO1: 7-year follow-up highlights the value of Olaparib maintenance Read More »
